Barer Sol J
- SEC CIK
- 0001247015
No open-market purchases or sales filed in the past year.
Current role at each company
- TEVA Teva Pharmaceutical Industries LtdDirectoras of Jun 8, 2026
- NEXI NexImmune, Inc.Directoras of Jul 7, 2023
- CFRX CONTRAFECT CorpDirectoras of May 18, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Barer Sol J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NEXI NexImmune, Inc.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 (view filing) | Mar 18 | 3 days | Barer Sol JDirector | PPurchase | +30.0K | $2.11 | +$63.3K | +2.1%1.45M after | |
| Mar 22, 2022 (view filing) | Mar 21 | 1 day | Barer Sol JDirector | PPurchase | +30.0K | $2.14 | +$64.2K | +2.1%1.48M after | |
| Mar 23, 2022 (view filing) | Mar 22 | 1 day | Barer Sol JDirector | PPurchase | +30.0K | $2.41 | +$72.3K | +2.0%1.51M after | |
| Mar 24, 2022 (view filing) | Mar 23 | 1 day | Barer Sol JDirector | PPurchase | +10.0K | $2.67 | +$26.7K | +0.7%1.52M after | |
| Jun 2, 2022 (view filing) | May 31-Jun 2 | 2 days | Barer Sol JDirector | PPurchase | +100.0K | $2.26 | +$226.0K | +6.9%1.56M after | 3 lots |
| Nov 17, 2022 (view filing)8:40 PM ET | Nov 16-17 | 1 day | Barer Sol JDirector | PPurchase | +200.0K | $0.4811 | +$96.2K | +13.0%1.74M after | 2 lots |
| Mar 31, 2023 (view filing)4:56 PM ET | Mar 30 | 1 day | Barer Sol JDirector | PPurchase | +400.0K | $0.4103 | +$164.1K | +22.0%2.22M after |